Heart Test Laboratories, Inc. (HSCS)
NASDAQ: HSCS · IEX Real-Time Price · USD
3.640
-0.250 (-6.43%)
At close: Jul 19, 2024, 12:00 AM
3.850
+0.210 (5.77%)
Pre-market: Jul 22, 2024, 8:47 AM EDT

Heart Test Laboratories Ratios and Metrics

Millions USD. Fiscal year is May - Apr.
Year Ending
CurrentApr 30, 2023Apr 30, 2022Apr 30, 2021Apr 30, 2020
Market Capitalization
29---
Market Cap Growth
-45.77%----
Enterprise Value
-49520
PE Ratio
--1.36---
PS Ratio
128.301678.48---
PB Ratio
0.2837.49---
P/FCF Ratio
-1.48-1.49---
P/OCF Ratio
-1.49-1.50---
EV/Sales Ratio
188.801660.11364.8991.996.95
EV/EBITDA Ratio
-0.59-1.41-1.18-1.03-0.12
EV/EBIT Ratio
-0.58-1.40-1.18-1.02-0.12
EV/FCF Ratio
-0.55-1.48-1.44-0.96-0.12
Debt / Equity Ratio
0.126.79-1.02-1.612.99
Debt / EBITDA Ratio
-0.18-0.26-1.39-1.35-0.25
Debt / FCF Ratio
-0.17-0.27-1.69-1.26-0.25
Quick Ratio
4.160.910.270.650.44
Current Ratio
5.091.470.561.471.35
Asset Turnover
0.000.000.010.01-
Interest Coverage
-16.41-25.13-11.99-17.51-1354.79
Return on Equity (ROE)
-381.90%-644.70%121.20%307.70%-
Return on Assets (ROA)
-134.20%-148.60%-240.40%-126.30%-
Return on Capital (ROIC)
-62.15%-340.28%-4402.17%-219.65%-303.45%
Earnings Yield
-267.82%-73.51%---
FCF Yield
-268.97%-67.00%---
Buyback Yield / Dilution
-552.76%-139.56%-0.15%--
Total Shareholder Return
-552.76%-139.56%-0.15%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).